nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Doxorubicin—peripheral nervous system neoplasm	0.574	1	CbGbCtD
Bimatoprost—AKR1C3—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00624	0.592	CbGdCrCtD
Bimatoprost—PTGFR—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00517	0.161	CbGpPWpGaD
Bimatoprost—AKR1C3—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.0043	0.408	CbGdCrCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000915	0.0285	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000895	0.0279	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000818	0.0255	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00081	0.0253	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000801	0.025	CbGpPWpGaD
Bimatoprost—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.000699	0.00182	CcSEcCtD
Bimatoprost—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000694	0.00181	CcSEcCtD
Bimatoprost—Infection—Topotecan—peripheral nervous system neoplasm	0.000694	0.00181	CcSEcCtD
Bimatoprost—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00069	0.0018	CcSEcCtD
Bimatoprost—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000688	0.0018	CcSEcCtD
Bimatoprost—Infection—Tretinoin—peripheral nervous system neoplasm	0.000688	0.0018	CcSEcCtD
Bimatoprost—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000685	0.00179	CcSEcCtD
Bimatoprost—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000679	0.00177	CcSEcCtD
Bimatoprost—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000679	0.00177	CcSEcCtD
Bimatoprost—Infection—Melphalan—peripheral nervous system neoplasm	0.000679	0.00177	CcSEcCtD
Bimatoprost—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000678	0.00177	CcSEcCtD
Bimatoprost—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000673	0.00176	CcSEcCtD
Bimatoprost—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000673	0.00176	CcSEcCtD
Bimatoprost—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00067	0.00175	CcSEcCtD
Bimatoprost—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000664	0.00173	CcSEcCtD
Bimatoprost—Inflammation—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00173	CcSEcCtD
Bimatoprost—Skin discolouration—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.00172	CcSEcCtD
Bimatoprost—Cough increased—Doxorubicin—peripheral nervous system neoplasm	0.000651	0.0017	CcSEcCtD
Bimatoprost—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.00169	CcSEcCtD
Bimatoprost—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000646	0.00169	CcSEcCtD
Bimatoprost—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.00168	CcSEcCtD
Bimatoprost—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000642	0.00167	CcSEcCtD
Bimatoprost—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000631	0.00165	CcSEcCtD
Bimatoprost—Cystitis noninfective—Epirubicin—peripheral nervous system neoplasm	0.000629	0.00164	CcSEcCtD
Bimatoprost—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000626	0.00163	CcSEcCtD
Bimatoprost—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000626	0.00163	CcSEcCtD
Bimatoprost—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00163	CcSEcCtD
Bimatoprost—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000622	0.00162	CcSEcCtD
Bimatoprost—Cystitis—Epirubicin—peripheral nervous system neoplasm	0.000622	0.00162	CcSEcCtD
Bimatoprost—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000619	0.00161	CcSEcCtD
Bimatoprost—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000617	0.00161	CcSEcCtD
Bimatoprost—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000617	0.00161	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000617	0.0192	CbGpPWpGaD
Bimatoprost—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000616	0.00161	CcSEcCtD
Bimatoprost—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000616	0.00161	CcSEcCtD
Bimatoprost—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000615	0.0016	CcSEcCtD
Bimatoprost—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.0016	CcSEcCtD
Bimatoprost—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00061	0.00159	CcSEcCtD
Bimatoprost—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00061	0.00159	CcSEcCtD
Bimatoprost—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000609	0.00159	CcSEcCtD
Bimatoprost—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000607	0.00158	CcSEcCtD
Bimatoprost—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000606	0.00158	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000606	0.0189	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000603	0.00157	CcSEcCtD
Bimatoprost—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000602	0.00157	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000598	0.00156	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000598	0.00156	CcSEcCtD
Bimatoprost—Pain—Topotecan—peripheral nervous system neoplasm	0.000597	0.00156	CcSEcCtD
Bimatoprost—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.000595	0.00155	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000593	0.0185	CbGpPWpGaD
Bimatoprost—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000592	0.00155	CcSEcCtD
Bimatoprost—Pain—Tretinoin—peripheral nervous system neoplasm	0.000592	0.00155	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000591	0.0184	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00059	0.00154	CcSEcCtD
Bimatoprost—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000588	0.00153	CcSEcCtD
Bimatoprost—Pain—Melphalan—peripheral nervous system neoplasm	0.000585	0.00153	CcSEcCtD
Bimatoprost—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.000582	0.00152	CcSEcCtD
Bimatoprost—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00152	CcSEcCtD
Bimatoprost—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.0015	CcSEcCtD
Bimatoprost—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00148	CcSEcCtD
Bimatoprost—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000567	0.00148	CcSEcCtD
Bimatoprost—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000562	0.00147	CcSEcCtD
Bimatoprost—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.00146	CcSEcCtD
Bimatoprost—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000557	0.00145	CcSEcCtD
Bimatoprost—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.00145	CcSEcCtD
Bimatoprost—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00144	CcSEcCtD
Bimatoprost—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000548	0.00143	CcSEcCtD
Bimatoprost—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.00143	CcSEcCtD
Bimatoprost—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000546	0.00142	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.00142	CcSEcCtD
Bimatoprost—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000539	0.00141	CcSEcCtD
Bimatoprost—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.00141	CcSEcCtD
Bimatoprost—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.0014	CcSEcCtD
Bimatoprost—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000535	0.0014	CcSEcCtD
Bimatoprost—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000523	0.00137	CcSEcCtD
Bimatoprost—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.00136	CcSEcCtD
Bimatoprost—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00052	0.00136	CcSEcCtD
Bimatoprost—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000518	0.00135	CcSEcCtD
Bimatoprost—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000516	0.00135	CcSEcCtD
Bimatoprost—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.00134	CcSEcCtD
Bimatoprost—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.00133	CcSEcCtD
Bimatoprost—Infection—Vincristine—peripheral nervous system neoplasm	0.000502	0.00131	CcSEcCtD
Bimatoprost—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000501	0.00131	CcSEcCtD
Bimatoprost—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000497	0.0013	CcSEcCtD
Bimatoprost—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000497	0.0013	CcSEcCtD
Bimatoprost—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000496	0.00129	CcSEcCtD
Bimatoprost—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000494	0.00129	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00049	0.0153	CbGpPWpGaD
Bimatoprost—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00049	0.00128	CcSEcCtD
Bimatoprost—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00049	0.00128	CcSEcCtD
Bimatoprost—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00049	0.00128	CcSEcCtD
Bimatoprost—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000484	0.00126	CcSEcCtD
Bimatoprost—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000484	0.00126	CcSEcCtD
Bimatoprost—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.00125	CcSEcCtD
Bimatoprost—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000475	0.00124	CcSEcCtD
Bimatoprost—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00122	CcSEcCtD
Bimatoprost—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000467	0.00122	CcSEcCtD
Bimatoprost—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.00122	CcSEcCtD
Bimatoprost—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00121	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000463	0.00121	CcSEcCtD
Bimatoprost—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00121	CcSEcCtD
Bimatoprost—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000462	0.0012	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000461	0.0144	CbGpPWpGaD
Bimatoprost—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000458	0.0012	CcSEcCtD
Bimatoprost—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000458	0.0012	CcSEcCtD
Bimatoprost—PTGER3—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000458	0.0143	CbGpPWpGaD
Bimatoprost—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000457	0.00119	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.00118	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000451	0.0141	CbGpPWpGaD
Bimatoprost—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000451	0.00118	CcSEcCtD
Bimatoprost—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00117	CcSEcCtD
Bimatoprost—Infection—Cisplatin—peripheral nervous system neoplasm	0.000444	0.00116	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000442	0.0138	CbGpPWpGaD
Bimatoprost—Rash—Topotecan—peripheral nervous system neoplasm	0.00044	0.00115	CcSEcCtD
Bimatoprost—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00044	0.00115	CcSEcCtD
Bimatoprost—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000439	0.00114	CcSEcCtD
Bimatoprost—Cough—Etoposide—peripheral nervous system neoplasm	0.000438	0.00114	CcSEcCtD
Bimatoprost—Headache—Topotecan—peripheral nervous system neoplasm	0.000437	0.00114	CcSEcCtD
Bimatoprost—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000437	0.00114	CcSEcCtD
Bimatoprost—Rash—Tretinoin—peripheral nervous system neoplasm	0.000437	0.00114	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000437	0.00114	CcSEcCtD
Bimatoprost—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000436	0.00114	CcSEcCtD
Bimatoprost—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000436	0.00114	CcSEcCtD
Bimatoprost—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000434	0.00113	CcSEcCtD
Bimatoprost—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000434	0.00113	CcSEcCtD
Bimatoprost—Headache—Tretinoin—peripheral nervous system neoplasm	0.000434	0.00113	CcSEcCtD
Bimatoprost—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000433	0.00113	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000433	0.0135	CbGpPWpGaD
Bimatoprost—Pain—Vincristine—peripheral nervous system neoplasm	0.000433	0.00113	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.00113	CcSEcCtD
Bimatoprost—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000431	0.00113	CcSEcCtD
Bimatoprost—Rash—Melphalan—peripheral nervous system neoplasm	0.000431	0.00112	CcSEcCtD
Bimatoprost—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000431	0.00112	CcSEcCtD
Bimatoprost—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00112	CcSEcCtD
Bimatoprost—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000427	0.00112	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000424	0.00111	CcSEcCtD
Bimatoprost—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000418	0.00109	CcSEcCtD
Bimatoprost—Nausea—Topotecan—peripheral nervous system neoplasm	0.000415	0.00108	CcSEcCtD
Bimatoprost—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000411	0.00107	CcSEcCtD
Bimatoprost—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000411	0.00107	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000411	0.0128	CbGpPWpGaD
Bimatoprost—Infection—Etoposide—peripheral nervous system neoplasm	0.000407	0.00106	CcSEcCtD
Bimatoprost—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.00106	CcSEcCtD
Bimatoprost—Nausea—Melphalan—peripheral nervous system neoplasm	0.000406	0.00106	CcSEcCtD
Bimatoprost—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000404	0.00105	CcSEcCtD
Bimatoprost—PTGER1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000402	0.0125	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.0004	0.0125	CbGpPWpGaD
Bimatoprost—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00104	CcSEcCtD
Bimatoprost—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000399	0.00104	CcSEcCtD
Bimatoprost—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000398	0.00104	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.00103	CcSEcCtD
Bimatoprost—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000388	0.00101	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.00101	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00101	CcSEcCtD
Bimatoprost—Pain—Cisplatin—peripheral nervous system neoplasm	0.000382	0.000998	CcSEcCtD
Bimatoprost—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000377	0.000983	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000979	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000975	CcSEcCtD
Bimatoprost—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.000969	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000368	0.0115	CbGpPWpGaD
Bimatoprost—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000365	0.000953	CcSEcCtD
Bimatoprost—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000364	0.00095	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000364	0.0113	CbGpPWpGaD
Bimatoprost—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000363	0.000947	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00036	0.0112	CbGpPWpGaD
Bimatoprost—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000938	CcSEcCtD
Bimatoprost—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.000931	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000354	0.000923	CcSEcCtD
Bimatoprost—Pain—Etoposide—peripheral nervous system neoplasm	0.00035	0.000914	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000349	0.0109	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000906	CcSEcCtD
Bimatoprost—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.000906	CcSEcCtD
Bimatoprost—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000882	CcSEcCtD
Bimatoprost—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.000877	CcSEcCtD
Bimatoprost—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000334	0.000873	CcSEcCtD
Bimatoprost—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.000864	CcSEcCtD
Bimatoprost—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.000863	CcSEcCtD
Bimatoprost—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.000858	CcSEcCtD
Bimatoprost—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000846	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000323	0.0101	CbGpPWpGaD
Bimatoprost—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000321	0.000837	CcSEcCtD
Bimatoprost—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000837	CcSEcCtD
Bimatoprost—Rash—Vincristine—peripheral nervous system neoplasm	0.000319	0.000832	CcSEcCtD
Bimatoprost—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000319	0.000831	CcSEcCtD
Bimatoprost—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000831	CcSEcCtD
Bimatoprost—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000829	CcSEcCtD
Bimatoprost—Headache—Vincristine—peripheral nervous system neoplasm	0.000317	0.000827	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000317	0.00987	CbGpPWpGaD
Bimatoprost—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000816	CcSEcCtD
Bimatoprost—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.000814	CcSEcCtD
Bimatoprost—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000813	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000303	0.00946	CbGpPWpGaD
Bimatoprost—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000788	CcSEcCtD
Bimatoprost—Nausea—Vincristine—peripheral nervous system neoplasm	0.0003	0.000784	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000782	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000775	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000769	CcSEcCtD
Bimatoprost—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000294	0.000767	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000767	CcSEcCtD
Bimatoprost—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000765	CcSEcCtD
Bimatoprost—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000291	0.00076	CcSEcCtD
Bimatoprost—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00029	0.000756	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000752	CcSEcCtD
Bimatoprost—Rash—Cisplatin—peripheral nervous system neoplasm	0.000282	0.000736	CcSEcCtD
Bimatoprost—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000282	0.000735	CcSEcCtD
Bimatoprost—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000734	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000729	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000277	0.00864	CbGpPWpGaD
Bimatoprost—Tension—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000721	CcSEcCtD
Bimatoprost—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000713	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000272	0.00849	CbGpPWpGaD
Bimatoprost—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000708	CcSEcCtD
Bimatoprost—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000271	0.000707	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000703	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000266	0.00831	CbGpPWpGaD
Bimatoprost—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000693	CcSEcCtD
Bimatoprost—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000692	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000264	0.00824	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000261	0.00813	CbGpPWpGaD
Bimatoprost—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000679	CcSEcCtD
Bimatoprost—Rash—Etoposide—peripheral nervous system neoplasm	0.000258	0.000674	CcSEcCtD
Bimatoprost—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000258	0.000673	CcSEcCtD
Bimatoprost—Headache—Etoposide—peripheral nervous system neoplasm	0.000257	0.00067	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000667	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000255	0.00796	CbGpPWpGaD
Bimatoprost—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00066	CcSEcCtD
Bimatoprost—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00066	CcSEcCtD
Bimatoprost—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000649	CcSEcCtD
Bimatoprost—Cough—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000641	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00064	CcSEcCtD
Bimatoprost—Nausea—Etoposide—peripheral nervous system neoplasm	0.000243	0.000635	CcSEcCtD
Bimatoprost—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000634	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000242	0.00756	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00024	0.00748	CbGpPWpGaD
Bimatoprost—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000625	CcSEcCtD
Bimatoprost—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000623	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000621	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000237	0.00738	CbGpPWpGaD
Bimatoprost—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000611	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00061	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000232	0.00722	CbGpPWpGaD
Bimatoprost—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.0006	CcSEcCtD
Bimatoprost—Infection—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000595	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000593	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000227	0.00708	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000588	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000587	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000223	0.00696	CbGpPWpGaD
Bimatoprost—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000582	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000222	0.00693	CbGpPWpGaD
Bimatoprost—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000578	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000221	0.0069	CbGpPWpGaD
Bimatoprost—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000576	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000574	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000219	0.00682	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000218	0.00681	CbGpPWpGaD
Bimatoprost—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000566	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000551	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000544	CcSEcCtD
Bimatoprost—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000542	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000207	0.00646	CbGpPWpGaD
Bimatoprost—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000539	CcSEcCtD
Bimatoprost—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000534	CcSEcCtD
Bimatoprost—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000533	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000203	0.00633	CbGpPWpGaD
Bimatoprost—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000528	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000517	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000198	0.00616	CbGpPWpGaD
Bimatoprost—Pain—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000512	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000193	0.00603	CbGpPWpGaD
Bimatoprost—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000502	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000494	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000493	CcSEcCtD
Bimatoprost—AKR1C3—Disease—GNS—peripheral nervous system neoplasm	0.000189	0.00588	CbGpPWpGaD
Bimatoprost—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000488	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000187	0.00583	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000479	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000474	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000182	0.00566	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000181	0.00565	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000179	0.00559	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000179	0.00559	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000177	0.00553	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000176	0.00547	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000166	0.00516	CbGpPWpGaD
Bimatoprost—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00043	CcSEcCtD
Bimatoprost—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000424	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000162	0.00505	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GNS—peripheral nervous system neoplasm	0.000158	0.00492	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000157	0.00488	CbGpPWpGaD
Bimatoprost—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000398	CcSEcCtD
Bimatoprost—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000396	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—NME1—peripheral nervous system neoplasm	0.000151	0.00472	CbGpPWpGaD
Bimatoprost—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000392	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—COX2—peripheral nervous system neoplasm	0.000146	0.00454	CbGpPWpGaD
Bimatoprost—Rash—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000378	CcSEcCtD
Bimatoprost—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000377	CcSEcCtD
Bimatoprost—Headache—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000375	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000142	0.00443	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000142	0.00442	CbGpPWpGaD
Bimatoprost—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000367	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00014	0.00436	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000137	0.00427	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000137	0.00427	CbGpPWpGaD
Bimatoprost—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000356	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000134	0.00419	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000134	0.00418	CbGpPWpGaD
Bimatoprost—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00035	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000349	CcSEcCtD
Bimatoprost—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000347	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000132	0.00412	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PPP3R1—peripheral nervous system neoplasm	0.000132	0.00411	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000131	0.0041	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000131	0.00409	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000131	0.00408	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000127	0.00395	CbGpPWpGaD
Bimatoprost—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000329	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000124	0.00388	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000117	0.00365	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000115	0.00357	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ENO2—peripheral nervous system neoplasm	0.000114	0.00356	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000106	0.00332	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000106	0.0033	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000104	0.00325	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000104	0.00323	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000102	0.00319	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.0001	0.00313	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.0001	0.00312	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	9.83e-05	0.00306	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.82e-05	0.00306	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.78e-05	0.00305	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	9.62e-05	0.003	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.57e-05	0.00298	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ENO2—peripheral nervous system neoplasm	9.57e-05	0.00298	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.3e-05	0.0029	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.24e-05	0.00288	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SLC2A1—peripheral nervous system neoplasm	9.21e-05	0.00287	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.1e-05	0.00284	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.64e-05	0.0027	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.4e-05	0.00262	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—BCHE—peripheral nervous system neoplasm	8.08e-05	0.00252	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.01e-05	0.0025	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.71e-05	0.0024	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TH—peripheral nervous system neoplasm	7.6e-05	0.00237	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.35e-05	0.00229	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.35e-05	0.00229	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.19e-05	0.00224	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.94e-05	0.00216	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.46e-05	0.00202	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.33e-05	0.00197	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.28e-05	0.00196	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GNAS—peripheral nervous system neoplasm	6.21e-05	0.00193	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.15e-05	0.00192	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ABCB1—peripheral nervous system neoplasm	6.09e-05	0.0019	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.99e-05	0.00187	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.93e-05	0.00185	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.86e-05	0.00183	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.65e-05	0.00176	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.49e-05	0.00171	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.38e-05	0.00168	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.2e-05	0.00162	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.19e-05	0.00162	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTPN11—peripheral nervous system neoplasm	5.15e-05	0.00161	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.11e-05	0.00159	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—peripheral nervous system neoplasm	4.07e-05	0.00127	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.04e-05	0.00126	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.89e-05	0.00121	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.82e-05	0.00119	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.8e-05	0.00119	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.8e-05	0.00119	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.74e-05	0.00117	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.7e-05	0.00115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.66e-05	0.00114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.61e-05	0.00112	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.36e-05	0.00105	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NRAS—peripheral nervous system neoplasm	3.1e-05	0.000965	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.07e-05	0.000957	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.02e-05	0.000941	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.95e-05	0.000921	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—peripheral nervous system neoplasm	2.88e-05	0.000899	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.86e-05	0.000892	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.85e-05	0.000889	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.84e-05	0.000886	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.78e-05	0.000868	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.76e-05	0.000862	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.74e-05	0.000854	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.71e-05	0.000844	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.68e-05	0.000836	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.59e-05	0.000806	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.51e-05	0.000783	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.46e-05	0.000766	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.35e-05	0.000732	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.3e-05	0.000716	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HRAS—peripheral nervous system neoplasm	2.27e-05	0.000706	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.25e-05	0.000701	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.25e-05	0.0007	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.17e-05	0.000676	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.14e-05	0.000667	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.09e-05	0.000653	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.02e-05	0.00063	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—peripheral nervous system neoplasm	2e-05	0.000624	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.98e-05	0.000618	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.76e-05	0.000548	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.72e-05	0.000536	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.68e-05	0.000524	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000522	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.66e-05	0.000517	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.64e-05	0.000513	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.59e-05	0.000495	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.48e-05	0.000462	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000453	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.4e-05	0.000437	CbGpPWpGaD
